[:no]Nye publikasjoner[:en]New Publications[:]

[:no]Basert på siste ukes søk på “Department of Clinical Science AND Bergen”. Hvis du har publikasjoner som ikke favnes av dette søket, send referansen til elin.opheim@uib.no.

Laryngeal response patterns influence the efficacy of mechanical assisted cough in amyotrophic lateral sclerosis.
Andersen T, Sandnes A, Brekka AK, Hilland M, Clemm H, Fondenes O, Tysnes OB, Heimdal JH, Halvorsen T, Vollsæter M, Røksund OD.
Thorax. 2016 May 12

Readmission and mortality one year after acute hospitalization in older patients with explained and unexplained anemia – a prospective observational cohort study.
Abrahamsen JF, Monsen AL, Landi F, Haugland C, Nilsen RM, Ranhoff AH.
BMC Geriatr. 2016 May 24;16(1):109.

Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial.
Henriksen TE, Skrede S, Fasmer OB, Schoeyen H, Leskauskaite I, Bjørke-Bertheussen J, Assmus J, Hamre B, Grønli J, Lund A.
Bipolar Disord. 2016 May;18(3):221-32.

Maternal plasma total neopterin and kynurenine/tryptophan levels during pregnancy in relation to asthma development in the offspring.
Magnus MC, Karlstad Ø, Midtun Ø, Håberg SE, Tunheim G, Parr CL, Nafstad P, London SJ, Nilsen RM, Ueland PM, Nystad W.
J Allergy Clin Immunol. 2016 Apr 20.

Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies.
Héquet D, Pascual M, Lartey S, Pathirana RD, Bredholt G, Hoschler K, Hullin R, Meylan P, Cox RJ, Manuel O.
Vaccine. 2016 May 21.[:en]Based on last week’s search for “Department of Clinical Science AND Bergen”. If you have publications which are not covered by this search, send the reference to elin.opheim@uib.no.

Laryngeal response patterns influence the efficacy of mechanical assisted cough in amyotrophic lateral sclerosis.
Andersen T, Sandnes A, Brekka AK, Hilland M, Clemm H, Fondenes O, Tysnes OB, Heimdal JH, Halvorsen T, Vollsæter M, Røksund OD.
Thorax. 2016 May 12

Readmission and mortality one year after acute hospitalization in older patients with explained and unexplained anemia – a prospective observational cohort study.
Abrahamsen JF, Monsen AL, Landi F, Haugland C, Nilsen RM, Ranhoff AH.
BMC Geriatr. 2016 May 24;16(1):109.

Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial.
Henriksen TE, Skrede S, Fasmer OB, Schoeyen H, Leskauskaite I, Bjørke-Bertheussen J, Assmus J, Hamre B, Grønli J, Lund A.
Bipolar Disord. 2016 May;18(3):221-32.

Maternal plasma total neopterin and kynurenine/tryptophan levels during pregnancy in relation to asthma development in the offspring.
Magnus MC, Karlstad Ø, Midtun Ø, Håberg SE, Tunheim G, Parr CL, Nafstad P, London SJ, Nilsen RM, Ueland PM, Nystad W.
J Allergy Clin Immunol. 2016 Apr 20.

Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies.
Héquet D, Pascual M, Lartey S, Pathirana RD, Bredholt G, Hoschler K, Hullin R, Meylan P, Cox RJ, Manuel O.
Vaccine. 2016 May 21.[:]

[:no]Ettervekst [:en]Aftergrowth[:]

[:no]InstitRæder_portrettuttledelsen kommer til å bruke den nye strategiplanen aktivt som poengtert i Per sin leder siste uke.  I et av underpunktene for Rekruttering-strategi (RIK1-T2) har vi skrevet at:

Klinisk institutt K2 skal stimulere forskningsgruppeledere til å identifisere fremragende interne og eksterne (utenlandske) kandidater og melde inn kandidater til Instituttleder som vil følge opp disse med karriererådgivning ved forskningsrådgiver.

Ettervekst er viktig, ikke bare for hårete prosjekter, men også for instituttet. Jeg ber dere tipse Per, Jone, Eystein eller meg på navn som kan være aktuelle når instituttet skal legge kabalen for fremtidige faste vitenskapelige stillinger. Vi ønsker rekruttering av fremragende kandidater, enten de nå befinner seg i Bergen eller i det store Utland. Vi har skrevet merittbaserte kriterier i tillegg til behovsbaserte kriterier i strategiplanen. Med meritter har vi presisert publikasjoner av høy kvalitet med høy siteringsgrad og sentrale forfatterroller, økende trend i publikasjons-kvalitet og kvantitet, tidlig oppnåelse av høy h-indeks og demonstrert uavhengighet og evne til å skaffe ekstern finansiering samt undervisningsmeritter.

Helge[:en]Ræder_portrettThe Department of Clinical Science is going to use the new strategic plan actively as emphasized in the editorial of Per last week. In one of the paragraphs on Recruitment Strategy (RIK1-T2), we wrote that:

Department of Clinical Science will stimulate group leaders to identify outstanding internal and external (foreign) candidates and submit names of potential candidates to the Department which will follow up these candidates with career counseling by the research advisor.

Aftergrowth is important for the Department. I encourage you all to let us know the names that may be relevant when the Department will plan future permanent academic positions. We wish to recruit outstanding candidates, whether they are located in Bergen or abroad. We have written merit-based criteria in addition to need-based criteria in the strategic plan. As merits we have emphasized high impact publications with high citation levels and key author roles, increasing trend in the publication quality and quantity, early achievement of a high h-index and demonstrated independence and ability to obtain external funding and teaching merits.

Helge[:]

[:no]Foredrag – Bass Hassan[:en]Lecture – Bass Hassan[:]

[:no]Under følger tittel på to foredrag som professor Bass Hassan – en ledende onkolog og forsker ved Lincoln College og Sir William Dunn School of Pathology, University of Oxford.
Place: Stort Auditorium, Sentralblokken, HUS 1. Juni kl 11.30 (1) og 13.00 (2).

Det første foredraget er spesielt interessant for biologer og basalforskere, samt klinikere som er interessert i translasjonell kreftforskning.

Det andre foredraget er mer rettet mot leger/klinikere og omhandler hvilken rolle genomikk kan spille i onkologifaget.

Foredragene planlegges direkte overført til Radiumhospitalet og Stavanger Universitetssykehus.

  1. Kl. 11.45 “Evolution and translation of the IGF2:IGF2R interaction»
    Focused on Bass Hassan’s main laboratory work: the evolution of the protein interaction between the products of two imprinted genes, genes that are also deregulated in cancer.
  2. Kl. 13.00 “Oncology in rare cancers, what we do and don’t know»
    A general update on oncology in rare cancers such as sarcoma which will include where genomics might and might not have impact.  Aspects of GIST as well as bone and soft tissue oncology will be presented, and discussion encouraged.

[:en]Below the title of the two speeches as Professor Bass Hassan – a leading oncologist and researcher at Lincoln College and Sir William Dunn School of Pathology, University of Oxford. Place: Stort Auditorium, Sentralblokken, HUS June 1st 11.30 AM (1) and 1:00 PM (2).

The first lecture is particularly interesting for biologists and basic researchers and clinicians interested in translational cancer Research.

The second lecture is more geared toward physicians / clinicians and discusses the role that genomics can play in oncology subject.

The lectures are planned directly transferred to the Norwegian Radium Hospital and Stavanger University Hospital.

  1. Kl. 11.45 AM “Evolution and translation of the IGF2:IGF2R interaction»
    Focused on Bass Hassan’s main laboratory work: the evolution of the protein interaction between the products of two imprinted genes, genes that are also deregulated in cancer.
  2. Kl. 1:00 PM “Oncology in rare cancers, what we do and don’t know»
    A general update on oncology in rare cancers such as sarcoma which will include where genomics might and might not have impact.  Aspects of GIST as well as bone and soft tissue oncology will be presented, and discussion encouraged.

 [:]

[:no]K1/K2 seminarserie 2016[:en]K1/K2 seminarseries 2016[:]

[:no]Vi har gleden av å invitere alle til neste K1/K2 seminar onsdag 1.juni!

Arnt-Ove Hovden, PhD, MSc, Medical Manager Respiratory, Boehringer Ingelheim Norway KS

A PhD completed –so what now? As an alumni of Gades institute (now a part of K2), I will talk about what to expect after graduating and for many -leaving the safe haven of academia. I will focus on the experiences that I have had after changing career path, first into the biotech sector and later into the pharmaceutical industry at Boehringer Ingelheim. As my current role is Medical Manager for a lung disease (Idiopathic lung fibrosis), I will also discuss that as to how a background from for instance the K2 institute, might be very valuable for the industry and how that has enabled me to work with a novel drug targeting FGFR, PDGF and VEGF. The main focus of my talk will, however, be the transferable skills that you develop during your studies and how that will serve you well in the rest of your professional career. Questions are encouraged, with the aim of broaden your horizons and perhaps give rise to new ideas of how to plan for the time to come!
Tid: Onsdag , 1 juni, 14.15-15.00
Sted: Stort Auditorium, 3 etasje, Sentralblokken
Chair: Silke Appel

Pizza serveres fra 14:05-14.15.
Everyone is welcome!

Se vedlegg for abstrakt.[:en]We wish to invite you all to the next K1/K2 Seminar in 2016. Wednesday June 1!

Arnt-Ove Hovden, PhD, MSc, Medical Manager Respiratory, Boehringer Ingelheim Norway KS

A PhD completed –so what now? As an alumni of Gades institute (now a part of K2), I will talk about what to expect after graduating and for many -leaving the safe haven of academia. I will focus on the experiences that I have had after changing career path, first into the biotech sector and later into the pharmaceutical industry at Boehringer Ingelheim. As my current role is Medical Manager for a lung disease (Idiopathic lung fibrosis), I will also discuss that as to how a background from for instance the K2 institute, might be very valuable for the industry and how that has enabled me to work with a novel drug targeting FGFR, PDGF and VEGF. The main focus of my talk will, however, be the transferable skills that you develop during your studies and how that will serve you well in the rest of your professional career. Questions are encouraged, with the aim of broaden your horizons and perhaps give rise to new ideas of how to plan for the time to come!

Time: Onsdag , 1 juni, 14.15-15.00
Place: Stort Auditorium, 3 etasje, Sentralblokken
Chair: Silke Appel

Pizza is served between 14:05-14.15.
Everyone is welcome.

See attachment for abstract.[:]

[:no]Nye publikasjoner[:en]New Publications[:]

[:no]Basert på siste ukes søk på “Department of Clinical Science AND Bergen”. Hvis du har publikasjoner som ikke favnes av dette søket, send referansen til elin.opheim@uib.no.

Lipodystrophy Due to Adipose Tissue Specific Insulin Receptor Knockout Results in Progressive NAFLD.
Softic S, Boucher J, Solheim MH, Fujisaka S, Haering MF, Homan EP, Winnay J, Perez-Atayde AR, Kahn CR.
Diabetes. 2016 May 10.

Adipose tissue is prominent in salivary glands of Sjögren’s syndrome patients and appears to influence the microenvironment in these organs.
Skarstein K, Aqrawi LA, Øijordsbakken G, Jonsson R, Jensen JL.
Autoimmunity. 2016 May 20:1-9.

Postinfectious and sporadic functional gastrointestinal disorders have different prevalences and rates of overlap: results from a controlled cohort study 3 years after acute giardiasis.
Wensaas KA, Hanevik K, Hausken T, Eide GE, Langeland N, Mørch K, Rortveit G.
Neurogastroenterol Motil. 2016 May 18.

Epidemiology and health related quality of life in hypoparathyroidism in Norway.
Astor MC, Løvås K, Debowska A, Eriksen EF, Evang JA, Fossum C, Fougner KJ, Holte SE, Lima K, Moe RB, Myhre AG, Kemp EH, Nedrebø BG, Svartberg J, Husebye ES.
J Clin Endocrinol Metab. 2016 May 17:jc20161477.

Personality and overweight in 6-12-year-old children.
Hampson SE, Vollrath ME, Júlíusson PB.
Pediatr Obes. 2015 Oct;10(5):e5-7.[:en]Based on last week’s search for “Department of Clinical Science AND Bergen”. If you have publications which are not covered by this search, send the reference to elin.opheim@uib.no.

Lipodystrophy Due to Adipose Tissue Specific Insulin Receptor Knockout Results in Progressive NAFLD.
Softic S, Boucher J, Solheim MH, Fujisaka S, Haering MF, Homan EP, Winnay J, Perez-Atayde AR, Kahn CR.
Diabetes. 2016 May 10.

Adipose tissue is prominent in salivary glands of Sjögren’s syndrome patients and appears to influence the microenvironment in these organs.
Skarstein K, Aqrawi LA, Øijordsbakken G, Jonsson R, Jensen JL.
Autoimmunity. 2016 May 20:1-9.

Postinfectious and sporadic functional gastrointestinal disorders have different prevalences and rates of overlap: results from a controlled cohort study 3 years after acute giardiasis.
Wensaas KA, Hanevik K, Hausken T, Eide GE, Langeland N, Mørch K, Rortveit G.
Neurogastroenterol Motil. 2016 May 18.

Epidemiology and health related quality of life in hypoparathyroidism in Norway.
Astor MC, Løvås K, Debowska A, Eriksen EF, Evang JA, Fossum C, Fougner KJ, Holte SE, Lima K, Moe RB, Myhre AG, Kemp EH, Nedrebø BG, Svartberg J, Husebye ES.
J Clin Endocrinol Metab. 2016 May 17:jc20161477.

Personality and overweight in 6-12-year-old children.
Hampson SE, Vollrath ME, Júlíusson PB.
Pediatr Obes. 2015 Oct;10(5):e5-7.[:]